Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q1 2025
Harvard Apparatus Regenerative Technology (HRGN) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 14, 2025
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $45K for the first quarter 2025 (Q1 2025), -21% from a year earlier and -83% from the quarter before.
Harvard Apparatus Regenerative Technology, Q1 2025: revenue $45K (-21% year over year), net loss $1.7M, operating cash flow −$758K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45K | -83% | -21% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$758K | — | — |
What changed
Revenue was $45K in Q1 2025, down 21% year over year and down 83% from the previous quarter.
Operating costs exceeded revenue by $1.7M, an operating margin of -3711.1%. Total costs fell 17% while revenue fell 21%. The fastest-growing cost line was Cost of revenue (+175%). The quarter ended with a net loss of $1.7M, wider than the previous quarter's $1.3M loss.
Operating cash flow was −$758K. Non-cash charges added back $2K of depreciation and $485K of share-based compensation. Working capital and other items added $414K.
Questions
What was Harvard Apparatus Regenerative Technology's revenue in the first quarter 2025?
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $45K for the first quarter 2025 (Q1 2025), -21% from a year earlier and -83% from the quarter before.
Source: Harvard Apparatus Regenerative Technology 10-Q on SEC EDGAR.